Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 19Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer 1

Interventions

3-Iodobenzylguanidine 2Cyclophosphamide 2Gemcitabine 2Insulin Infusion Systems 2Powders 2Suspensions 2balstilimab 2leronlimab 2ruxolitinib 2talquetamab 2Abiraterone Acetate 1Alpelisib 1Androgen Antagonists 1Asparaginase 1Bone Marrow Transplantation 1Capecitabine 1Docetaxel 1Eflornithine 1FANG vaccine 1HMPL-013 1Hydrocortisone 1Immunotherapy, Adoptive 1LY3023414 1Magnetic Resonance Spectroscopy 1Methionine 1Nivolumab 1Paclitaxel 1Peripheral Blood Stem Cell Transplantation 1Prednisolone 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × patritumab deruxtecan × 1 year × Clear all
NCT06099639 2025-06-08

Medical Access Program for Patritumab Deruxtecan

Daiichi Sankyo

No longer available
Thoracic

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡